|Description||LY-207702 is a difluorinated purine nucleoside. It exhibits antitumor activity in preclinical models. It was developed by Eli Lilly & Co.|
|Synonyms||LY 207702; LY-207702; LY207702. 2',2'-Difluorodeoxyribofuranosyl-2,6-diaminopurine;5-(2,6-diamino-7H-purin-8-yl)-4,4-difluoro-2-(hydroxymethyl)oxolan-3-ol;9-(2-Deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-9H-purine-2,6-diamine;(2R,3R)-5-(2,6-diamino-7H-purin-8-yl)-4,4-difluoro-2-(hydroxymethyl)oxolan-3-ol;9H-Purine-2,6-diamine, 9-(2-deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-|
|Solubility||10 mM in DMSO|
|Application||LY-207702 exhibits antitumor activity.|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Boiling Point||725.3±70.0 °C | Condition: Press: 760 Torr|
|Density||2.17±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr|
|Current Developer||LY-207702 was developed by Eli Lilly & Co.|
ZJ 43 is a potent inhibitor of glutamate carboxypeptidase II and III (GCP II and III/NAAG peptidase/NAALADase) (Ki = 0.8 and 23 nM, respectively). It inhibits t...
Cimifugin is a major components of Yu-ping-feng-san, a Chinese medical formula that is used clinically for allergic diseases and characterized by reducing aller...
Rehmannioside D is a carotenoid glycoside extracted from the roots of Rehmannia glutinosa.
INH1 is a cell-permeable Hec1 inhibitor, which specifically disrupts the Hec1/Nek2 interaction.
Zoniporide dihydrochloride is a potent sodium-hydrogen exchanger isoform 1 (NHE1) inhibitor with selectivity over other NHE isoforms (Ki = 14, 2200 and 220000 n...
BPIPP is a non-competitive guanylyl cyclase (GC) and adenylyl cyclase (AC) inhibitor. It downregulates cAMP and cGMP synthesis, suppresses cGMP accumulation in ...
MI-463, a thienopyrimidine derivative, has been found to be a menin inhibitor that could be significant in Leukaemia studies.
Picloxydine, a heterocyclic biguanide, has antibacterial and antiplaque properties. In vitro studies have shown that the antibacterial<br/>properties of chlorhe...